Repare Therapeutics (RPTX) Short Interest Ratio & Short Volume $1.37 -0.09 (-6.16%) (As of 10:44 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Repare Therapeutics Short Interest DataRepare Therapeutics (RPTX) has a short interest of 576,500 shares, representing 2.00% of the float (the number of shares available for trading by the public). This marks a -5.48% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.6, indicating that it would take 4.6 days of the average trading volume of 197,891 shares to cover all short positions.Current Short Interest576,500 sharesPrevious Short Interest609,900 sharesChange Vs. Previous Month-5.48%Dollar Volume Sold Short$1.89 millionShort Interest Ratio4.6 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares42,511,000 sharesFloat Size28,770,000 sharesShort Percent of Float2.00%Today's Trading Volume351,177 sharesAverage Trading Volume197,891 sharesToday's Volume Vs. Average177% Short Selling Repare Therapeutics? Sign up to receive the latest short interest report for Repare Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRPTX Short Interest Over TimeRPTX Days to Cover Over TimeRPTX Percentage of Float Shorted Over Time Ad Crypto 101 MediaDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! Repare Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024576,500 shares $1.89 million -5.5%2.0%4.6 $3.28 11/15/2024609,900 shares $1.90 million -18.7%2.1%5.3 $3.11 10/31/2024749,700 shares $2.51 million +4.6%2.6%7.3 $3.35 10/15/2024717,000 shares $2.41 million +0.7%2.5%6.8 $3.36 9/30/2024712,300 shares $2.45 million -3.6%2.5%5.8 $3.44 9/15/2024738,900 shares $2.61 million +2.4%2.6%6.3 $3.53 Get the Latest News and Ratings for RPTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Repare Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024721,300 shares $2.10 million -2.8%2.5%6.1 $2.91 8/15/2024741,700 shares $2.23 million -0.8%2.6%5.2 $3.00 7/31/2024747,500 shares $2.80 million -16.9%2.6%3 $3.74 7/15/2024900,000 shares $3.24 million +4.0%3.1%3.6 $3.60 6/30/2024865,200 shares $2.86 million +51.1%3.0%3.6 $3.30 6/15/2024572,600 shares $2.18 million +17.8%2.0%2.3 $3.80 5/31/2024485,900 shares $1.69 million -7.3%1.7%2.1 $3.48 5/15/2024524,300 shares $1.87 million -23.2%1.8%2.5 $3.57 4/30/2024682,500 shares $2.12 million +12.2%2.4%3.5 $3.10 4/15/2024608,300 shares $2.11 million -10.7%2.1%4.7 $3.47 3/31/2024681,000 shares $3.21 million +3.4%2.4%4.6 $4.71 3/15/2024658,600 shares $3.48 million -11.4%2.3%4.2 $5.29 2/29/2024743,300 shares $5.17 million -8.5%2.6%3.7 $6.95 2/15/2024812,500 shares $5.65 million -52.8%2.8%3.6 $6.95 1/31/20241,720,000 shares $11.25 million -20.0%5.4%5.7 $6.54 1/15/20242,150,000 shares $14.06 million -2.7%6.8%6 $6.54 12/31/20232,210,000 shares $16.13 million -12.3%7.0%5.9 $7.30 12/15/20232,520,000 shares $17.01 million -7.4%7.9%6.9 $6.75 11/30/20232,720,000 shares $14.01 million +25.9%8.6%7.8 $5.15 11/15/20232,160,000 shares $11.43 million +24.1%6.8%6.9 $5.29 10/31/20231,740,000 shares $5.92 million +10.8%5.5%7.4 $3.40 10/15/20231,570,000 shares $8.29 million +23.6%4.9%9.9 $5.28 9/30/20231,270,000 shares $15.34 million +1.6%4.0%10.8 $12.08 9/15/20231,250,000 shares $12.90 million +4.2%3.9%12.3 $10.32 8/31/20231,200,000 shares $11.71 million -3.2%3.8%12.5 $9.76 8/15/20231,240,000 shares $12.05 million +0.8%3.9%12.1 $9.72 7/31/20231,230,000 shares $11.32 million -5.4%3.9%12.6 $9.20 7/15/20231,300,000 shares $14.14 million +2.4%4.1%13.7 $10.88 6/30/20231,270,000 shares $13.44 million -5.9%4.0%12.4 $10.58 6/15/20231,350,000 shares $16.67 million +7.1%4.3%13 $12.35 5/31/20231,260,000 shares $13.37 million -2.3%4.0%12.2 $10.61 5/15/20231,290,000 shares $13.08 million -4.4%4.1%12.8 $10.14 4/30/20231,350,000 shares $12.10 million -12.9%4.3%12 $8.96 4/15/20231,550,000 shares $14.06 million -8.3%5.0%12.6 $9.07DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! 3/31/20231,690,000 shares $16.63 million +1.2%5.4%13.4 $9.84 3/15/20231,670,000 shares $16.60 million +6.4%5.4%11.6 $9.94 2/28/20231,570,000 shares $16.09 million +4.0%5.1%9.7 $10.25 2/15/20231,510,000 shares $17.41 million +4.9%4.9%9.2 $11.53 1/31/20231,440,000 shares $17.80 million -7.1%4.7%7.7 $12.36 1/15/20231,550,000 shares $19.92 million +22.1%5.0%8.8 $12.85 12/30/20221,270,000 shares $18.68 million +64.2%4.1%7.5 $14.71 12/15/2022773,300 shares $11.55 million -39.6%2.5%4.9 $14.93 11/30/20221,280,000 shares $20.52 million -18.0%4.2%8.9 $16.03 11/15/20221,560,000 shares $26.69 million +0.7%5.1%11.7 $17.11 10/31/20221,550,000 shares $23.34 million -1.9%5.1%12.6 $15.06 10/15/20221,580,000 shares $21.09 million -1.9%5.2%10.8 $13.35 9/30/20221,610,000 shares $19.53 million +4.6%5.3%10.5 $12.13 9/15/20221,540,000 shares $20.14 million -4.4%5.0%9.1 $13.08 8/31/20221,610,000 shares $19.19 million +5.2%5.3%7.9 $11.92 8/15/20221,530,000 shares $18.74 million -26.1%5.0%1.8 $12.25 7/31/20222,070,000 shares $26.16 million -1.0%6.8%2.5 $12.64 7/15/20222,090,000 shares $30.45 million +2.0%6.8%2.5 $14.57 6/30/20222,050,000 shares $28.68 million -15.6%6.7%2.4 $13.99 6/15/20222,430,000 shares $32.73 million +30.7%8.0%2.9 $13.47 5/31/20221,860,000 shares $17.07 million -4.6%6.4%2.3 $9.18 5/15/20221,950,000 shares $17.08 million -24.7%6.7%11.6 $8.76 4/30/20222,590,000 shares $28.49 million -12.8%8.9%15.8 $11.00 4/15/20222,970,000 shares $34.07 million +0.3%10.2%17.1 $11.47 3/31/20222,960,000 shares $42.15 million +6.1%10.2%17.2 $14.24 3/15/20222,790,000 shares $33.81 million -0.4%9.6%16.7 $12.12 2/28/20222,800,000 shares $45.00 million +3.7%9.7%16.3 $16.07 2/15/20222,700,000 shares $40.37 million +1.9%9.4%14.7 $14.95 1/31/20222,650,000 shares $40.89 million +4.3%9.1%14.9 $15.43 1/15/20222,540,000 shares $38.68 million +2.0%8.8%13.1 $15.23 12/31/20212,490,000 shares $52.51 million -2.7%9.8%12.3 $21.09 12/15/20212,560,000 shares $52.86 million +4.1%10.1%10.4 $20.65 11/30/20212,460,000 shares $57.74 million +6.0%9.8%9.8 $23.47 11/15/20212,320,000 shares $62.73 million +6.9%9.2%9.8 $27.04 10/29/20212,170,000 shares $54.27 million +26.9%9.6%9.6 $25.01 10/15/20211,710,000 shares $37.72 million +131.6%8.5%8.7 $22.06 9/30/2021738,500 shares $19.38 million -12.0%3.7%4 $26.24 9/15/2021838,700 shares $25.83 million -7.1%4.2%6.8 $30.80 8/31/2021903,000 shares $30.70 million -7.1%4.5%6.9 $34.00 8/13/2021972,400 shares $33.17 million +3.0%4.9%7.3 $34.11 7/30/2021943,900 shares $31.53 million +45.8%4.8%6.4 $33.40 7/15/2021647,500 shares $18.96 million -8.8%2.8%4.3 $29.28 6/30/2021709,600 shares $22.13 million -2.5%3.1%5 $31.18 6/15/2021728,100 shares $23.05 million -5.0%3.2%5.1 $31.66 5/28/2021766,500 shares $24.77 million -3.3%3.3%5.2 $32.32 5/14/2021792,600 shares $24.72 million +4.2%3.2%5.3 $31.19 4/30/2021760,900 shares $25.00 million +3.9%3.4%5.2 $32.86 4/15/2021732,300 shares $25.07 million +17.9%3.3%4.8 $34.24 3/31/2021621,100 shares $18.20 million +5.2%2.8%4.1 $29.31 3/15/2021590,300 shares $16.38 million +11.2%2.4%3.7 $27.75DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! 2/26/2021531,100 shares $17.04 million +10.0%2.5%3.6 $32.08 2/12/2021483,000 shares $17.10 million +6.2%2.3%3.2 $35.40 1/29/2021454,900 shares $16.49 million -2.7%2.4%3.4 $36.24 1/15/2021467,600 shares $20.59 million No Change2.6%3.6 $44.04 RPTX Short Interest - Frequently Asked Questions What is Repare Therapeutics' current short interest? Short interest is the volume of Repare Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 576,500 shares of RPTX short. 2.00% of Repare Therapeutics' shares are currently sold short. Learn More on Repare Therapeutics' current short interest. What is a good short interest ratio for Repare Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RPTX shares currently have a short interest ratio of 5.0. Learn More on Repare Therapeutics's short interest ratio. What is a good short interest percentage for Repare Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.00% of Repare Therapeutics' floating shares are currently sold short. Is Repare Therapeutics' short interest increasing or decreasing? Repare Therapeutics saw a decline in short interest during the month of November. As of November 30th, there was short interest totaling 576,500 shares, a decline of 5.5% from the previous total of 609,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Repare Therapeutics' float size? Repare Therapeutics currently has issued a total of 42,511,000 shares. Some of Repare Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Repare Therapeutics currently has a public float of 28,770,000 shares. How does Repare Therapeutics' short interest compare to its competitors? 2.00% of Repare Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Repare Therapeutics: Corvus Pharmaceuticals, Inc. (5.46%), Arcturus Therapeutics Holdings Inc. (17.78%), Kodiak Sciences Inc. (2.73%), ChromaDex Co. (4.15%), MeiraGTx Holdings plc (1.89%), SIGA Technologies, Inc. (9.13%), REGENXBIO Inc. (10.62%), KalVista Pharmaceuticals, Inc. (14.69%), Organogenesis Holdings Inc. (11.86%), Zevra Therapeutics, Inc. (8.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Repare Therapeutics stock? Short selling RPTX is an investing strategy that aims to generate trading profit from Repare Therapeutics as its price is falling. RPTX shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Repare Therapeutics? A short squeeze for Repare Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RPTX, which in turn drives the price of the stock up even further. How often is Repare Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RPTX, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies CRVS Short Interest Data ARCT Short Interest Data KOD Short Interest Data CDXC Short Interest Data MGTX Short Interest Data SIGA Short Interest Data RGNX Short Interest Data KALV Short Interest Data ORGO Short Interest Data ZVRA Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RPTX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repare Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Repare Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
